Abciximab/Heparin Therapy for Left Ventricular Assist Device Implantation in Patients With Heparin-Induced Thrombocytopenia

Article ID	Journal	Published Year	Pages	File Type
8652888	The Annals of Thoracic Surgery	2018	7 Pages	PDF

Abstract

This is the first report of a novel abciximab/heparin protocol for LVAD implantation in patients with HIT. The preliminary results suggest the feasibility and safety of this protocol.

Keywords

GPi PF4 LVAD PFO IJV IABP FFP RVAD UFH MVR INTERMACS i.v.LAA ACT HeartMate APTT PRBC POD CPB Interagency Registry for Mechanically Assisted Circulatory Support Serotonin release assay Pulmonary embolism AVR HIT cardiopulmonary bypass ICU intensive care unit Patent foramen ovale coronary artery bypass grafting mitral valve repair Deep vein thrombosis DVT Heparin-induced thrombocytopenia aortic valve repair tricuspid valve replacement CABG Sra OHT Intravenous right ventricular assist device left ventricular assist device Left atrium postoperative day activated partial thromboplastin time activated clotting time left atrial appendage Platelet factor 4 cardiovascular TVR unfractionated heparin Internal jugular vein Antibody fresh frozen plasma orthotopic heart transplant optical density Cardiomyopathy packed red blood cells

Related Topics

Health Sciences Medicine and Dentistry Cardiology and Cardiovascular Medicine

Abciximab/Heparin Therapy for Left Ventricular Assist Device Implantation in Patients With Heparin-Induced Thrombocytopenia

Authors

Chia-Ling MD, Paolo C. MD, Andrew MD, David MD, Douglas L. PharmD, Jiho BS, Michael P. BMS, Koji MD, PhD, Paul A. MD, Melana MD, Arthur R. MD, Yoshifumi MD, PhD, Hiroo MD, PhD,